Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

discus dental australia pty limited -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

discus dental australia pty limited -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

discus dental australia pty limited -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

discus dental australia pty limited -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

discus dental australia pty limited -

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

viatris limited - vancomycin hydrochloride 513mg equivalent to 500 mg vancomycin;  ;  ;   - powder for infusion - 500 mg - active: vancomycin hydrochloride 513mg equivalent to 500 mg vancomycin       - vancomycin hydrochloride is indicated for potentially life-threatening infections which cannot be treated with another effective, less toxic antimicrobial drug, including the penicillins and cephalosporins. vancomycin hydrochloride is useful in therapy of severe staphylococcal (including methicillin resistant staphylococcal) infections in patients who cannot receive or who have failed to respond to the penicillins and cephalosporins or who have infections with staphylococci that are resistant to other antibiotics. once sensitivity data are available, therapy should be adjusted accordingly. vancomycin hydrochloride is effective alone or in combination with an aminoglycoside for endocarditis caused by streptococcus viridans or s. bovis. for endocarditis caused by enterococci (e.g. strep. faecalis), vancomycin hydrochloride is effective only in combination with an aminoglycoside. vancomycin hydrochloride is effective for the treatment of diptheroid endocarditis. vancomycin hydrochloride is used in combination with rifampicin, an aminoglycoside, or both in early-onset prosthetic valve endocarditis caused by staph. epidermidis or diptheroids. the effectiveness of vancomycin has been documented in other infections due to staphylococci including osteomyelitis, pneumonia, septicaemia and skin and skin structure infections. when staphylococcal infections are localised and purulent, antibiotics are used as adjuncts to appropriate surgical measures. specimens for bacteriological cultures should be obtained in order to isolate and identify causative organisms and to determine their susceptibilities to vancomycin hydrochloride. vancomycin hydrochloride should be administered orally for the treatment of staphylococcal enterocolitis and antibiotic-associated pseudomembranous colitis (produced by c. difficile). parenteral administration of vancomycin hydrochloride alone is inappropriate for this indication.

Израел - Енглески - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ethinylestradiol; gestodene - coated tablets - ethinylestradiol 0.020 mg; gestodene 0.075 mg - gestodene and estrogen - gestodene and estrogen - contraceptive.

Израел - Енглески - Ministry of Health

cts chemical industries ltd, israel - valproic acid as sodium - tablets enteric coated - valproic acid as sodium 500 mg - valproic acid - valproic acid - generalized or partial epilepsy, secondary generalized epilepsy, mixed forms of epilepsy.

Израел - Енглески - Ministry of Health

cts chemical industries ltd, israel - valproic acid as sodium - syrup - valproic acid as sodium 40 mg/ml ml - valproic acid - valproic acid - generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.

Израел - Енглески - Ministry of Health

cts chemical industries ltd, israel - valproic acid as sodium - tablets enteric coated - valproic acid as sodium 200 mg - valproic acid - valproic acid - anti-epileptic.